Early, small trials suggested a beneficial effect of ALCAR with respect to cognitive decline (98-100), whereas later, larger trials found little-to-no effect compared to placebo (101-103)
Medications like Invokana block SGLT2, causing more glucose to leave the body through urine rather than being reabsorbed
Lilly's currently approved injection, Zepbound, and Novo Nordisk's Wegovy have shown weight loss of roughly 15% to 20% in different trials, according to Reuters, while Lilly's oral obesity pill, Foundayo, has delivered about 11% weight loss
Compounded medication may still be available if they fill a speicific individual patient need or dose that is not commercially available
RegenCen specializes in identifying these early hormonal shifts and providing thoughtful hormone therapy that evolves as the body changes
Follow-up Repeat glucose and CMP-related markers after 4-12 weeks or sooner if vomiting, dehydration, or glucose symptoms occur